Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
KILITCH | NSE
-1.10
-0.30%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
369.30
372.45
386.75
362.80
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products including gastroenterology anti-inflammatory anticonvulsant/antiepileptic anti-malarial aminoglycoside antibacterial anti-hypertensive anti-infective diagnostic sympathomimetic local anesthetic neurotonic uterine stimulant external preparation non-steroidal anti-inflammatory oncology ophthalmic and other drugs as well as vaccines and veterinary products in the form of ampoules vials and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops as well as Klavmox and Onecef products. The company also provides a range of oral formulations including tablets capsules dry syrup gripe water and oral powder and liquid in the antibiotic anti-diabetics cardiovascular and other areas. In addition it offers effervescent tablets and powders such as ROIPAR DUREGRA ROIVIT and PH-7; and various nutritional products such as CELTINE. Further the company provides C-Seal a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally it offers cosmetics and herbal products consisting of a range of oils lotions liquids creams and paste in skin personal and hair care categories as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes obesity libido and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
58.4%1 month
41.6%3 months
45.7%6 months
40.0%50.24
-
3.61
0.18
0.13
20.94
3.90
-
197.37M
5.97B
71.46M
-
2.41
-61.40
-8.50
8.32
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
74.80
Range1M
77.40
Range3M
89.95
Rel. volume
0.66
Price X volume
6.79M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
SAKAR | SAKAR | Drug Manufacturers-Specialty & Generic | 328.45 | 5.69B | 65.31 | 30.25% | |
Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 446.95 | 5.64B | -3.29% | 72.99 | 15.37% |
Zim Laboratories Limited | ZIMLAB | Drug Manufacturers-Specialty & Generic | 109.43 | 5.37B | -2.85% | 31.56 | 45.58% |
Venus Remedies Limited | VENUSREM | Drug Manufacturers-Specialty & Generic | 343.5 | 4.62B | -1.05% | 17.16 | 8.48% |
Brooks Laboratories Limited | BROOKS | Drug Manufacturers-Specialty & Generic | 153.56 | 4.03B | -2.00% | n/a | 8.60% |
Medico Remedies Limited | MEDICO | Drug Manufacturers-Specialty & Generic | 48 | 3.84B | 3.23% | 41.94 | 15.37% |
Par Drugs And Chemicals Limited | PAR | Drug Manufacturers-Specialty & Generic | 234.05 | 2.94B | -2.01% | 22.25 | 0.00% |
Alpa Laboratories Limited | ALPA | Drug Manufacturers-Specialty & Generic | 114.72 | 2.48B | -0.24% | 14.11 | 3.45% |
Vaishali Pharma Limited | VAISHALI | Drug Manufacturers-Specialty & Generic | 192.25 | 2.06B | -1.98% | 333.23 | 31.49% |
Mangalam Drugs & Organics Limited | MANGALAM | Drug Manufacturers-Specialty & Generic | 127.32 | 2.02B | -6.02% | n/a | 72.53% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bhagyanagar India Ltd | BHAGYANGR | Copper | 102.27 | 3.27B | -3.96% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 166.42 | 1.85B | -3.27% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 93.74 | 1.34B | -3.01% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.42 | 1.02B | -1.33% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.12 | 483.23M | 88.75 | 43.14% | |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.67 | 331.86M | -1.48% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 4.93 | 296.65M | -2.38% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 20.94 | 23.29 | Par |
Ent. to Revenue | 3.90 | 12.02 | Cheaper |
PE Ratio | 50.24 | 47.84 | Par |
Price to Book | 3.61 | 6.55 | Cheaper |
Dividend Yield | - | 0.59 | - |
Std. Deviation (3M) | 45.75 | 40.95 | Par |
Debt to Equity | 0.18 | 0.34 | Cheaper |
Debt to Assets | 0.13 | 0.17 | Cheaper |
Market Cap | 5.97B | 286.13B | Emerging |